Ryan & Maniskas, LLP Investigation of Receptos, Inc.

WAYNE, Pa., July 17, 2015 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Receptos, Inc. ("Receptos" or the "Company") (NASDAQ: RCPT) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Celgene Corporation in a transaction valued at approximately $7.2 billion.

If you own shares of Receptos and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at [phone] or to sign up online, visit: www.rmclasslaw.com/cases/rcpt.  You may also email Mr. Maniskas at [e-mail]. 

Under the terms of the agreement, shareholders of Receptos will receive $232.00 in cash for each share of Receptos they own.

Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Receptos for not acting in the Company's shareholders' best interests in connection with the sale process. 

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.  To learn more about the class action process, please visit: www.rmclasslaw.com.

CONTACT: Ryan & Maniskas, LLP
Richard A. Maniskas, Esquire
995 Old Eagle School Rd., Suite 311
Wayne, PA 19087
877-316-3218
www.rmclasslaw.com/cases/rcpt 
[e-mail] 

Logo - http://photos.prnewswire.com/prnh/20121112/MM11729LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-investigation-of-receptos-inc-300114966.html

SOURCE Ryan & Maniskas, LLP

Copyright 2015 PR Newswire